# Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

> **NCT00408538** · PHASE1 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 36 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** UC-781 microbicide gel (0.1% and 0.25%)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00408538
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2009-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408538, "Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00408538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*